Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumours [3]

European Journal of Cancer Part A

Volumn 32, Issue 10, 1996, Pages 1824-1825

  Zanon, C ^b   Grosso, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Cattedra di Chir Generale Servizio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN;

CATHETER; CLINICAL ARTICLE; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LETTER; LIVER CANCER; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030249215     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00179-7     Document Type: Letter

References (15)

1. 1. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional vs systemic continuous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 1987, 206, 685-693.
2. 2. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous vs hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver. The Northern California Oncology Trial. J Clin Oncol 1989, 7, 1646-1654.
3. 3. Martin JK, O'Connel NJ, Wieand HS, et al. Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990, 125, 1022-1027.
4. 4. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyridina in patients with liver metastases from colorectal carcinoma: a randomized trial. Ann Int Med 1987, 107, 459-465.
5. 5. Rougier P, Hay JM, Olivier JM, et al. A controlled multicentric trial of intrahepatic artery chemotherapy vs standard palliative treatment for colorectal liver metastases. Proc Am Soc Clin Oncol 1990, 9, 104.
6. 6. Arisawa Y, Sutanto WM, Fortunato L, Sigurdson ER. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy. Ann Surg Oncol 1995, 2, 114-120.
7. 7. Kemeny N, Conti JA, Cohen A, et al. Phase 2 study of hepatic arterial fluoxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994, 12, 2288-2295.
8. 8. Kemeny MM, Alava G, Oliver JM. The effect on liver metastases of arcadian patterned continuous hepatic artery infusion of FUDR. Hepato-Pancreatic-Biliary Surg 1994, 7, 219-224.
9. 9. Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer 1994, 73, 1134-1142.
10. 10. Takats PG, Kerr DJ, Poole CJ, Warren HW, McArdle CS. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer 1994, 2, 372-378.
11. 11. Boyle FM, Smith RC, Levi JA. Continuous hepatic artery infusion of 5-fluorouracil for metastatic colorectal cancer localised to the liver. Aust N Z J Med 1993, 1, 32-34.
12. 12. Lorenz M, Hottenrott C, Encke A. Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumours. Zentralbl Chir 1993, 118, 279-289.
13. 13. Sugarbaker PH, Steves MA. A cytoreductive approach to treatment of multiple liver metastases. J Surg Oncol 1993, 3 (Suppl.), 161-165.
14. 14. Kemeny N, Conti JA, Sigurdson E, et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer 1993, 71, 1964-1971.
15. 15. Yoshikawa M, Ebara M, Nakano T, Minoyama A, Sugiura N, Ohto M. Percutaneous transaxillary catheter insertion for hepatic artery infusion chemotherapy. Am J Roentgenol 1992, 158, 885-886.